Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

SPL

Santander Bank Polska

Starpharma Holdings Limited is an Australian company that specializes in the research, development, and commercialization of dendrimer products for various applications, especially in the pharmaceu...

Santander Bank Polska Annual Report 2023

Healthcare Biotechnology ASX 11-50

RYTM

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc., a leader in the biopharmaceutical industry, is pioneering innovative therapeutics for rare genetic diseases of obesity. Focused on the development and commercializatio...

Rhythm Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

XBIT

Xbiotech Inc

Austin-based XBiotech Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of True Human monoclonal antibodies for treating various diseases. Wi...

Xbiotech Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MORF

Morphic Holding, Inc.

Biopharmaceutical firm, Morphic Holding, Inc., has developed a range of oral small-molecule integrin therapeutics aimed at treating conditions such as autoimmune, cardiovascular and metabolic disea...

Morphic Holding, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

INFI

Infinity Pharmaceuticals

Cambridge-based clinical-stage biopharmaceutical company, Infinity Pharmaceuticals, Inc., solely dedicates itself to providing cancer patients with innovative medications. The company's primary foc...

Infinity Pharmaceuticals Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

ACHN

Achillion Pharmaceuticals Inc.

Flushing-based Achison Inc. operates as an internet advertiser via its website www.dazhong368.com. The company's web platform offers an array of markets, catering to both individuals and businesses...

Achillion Pharmaceuticals Inc. Annual Report 2017

Healthcare Biotechnology NASDAQ 51-200

TRVN

Trevena, Inc.

Biopharmaceutical company Trevena, Inc. is dedicated to developing and bringing to market innovative treatments for those living with central nervous system disorders. At the forefront of its produ...

Trevena, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ATRA

Atara Biotherapeutics

Atara Biotherapeutics, Inc. is a cutting-edge biotech company focused on developing innovative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases. Boasting an im...

Atara Biotherapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

RAPT

RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc., a California-based clinical-stage immunology-based biopharmaceutical company, has made significant strides in its mission to discover, develop, and commercialize oral small...

RAPT Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SAVA

Cassava Sciences, Inc.

Austin-based biotech firm Cassava Sciences, Inc. is focused on developing innovative drugs to combat neurodegenerative diseases, with its lead product candidate being the promising small molecule d...

Cassava Sciences, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

MYOK

Myokardia Inc

MyoKardia is a South San Francisco-based clinical-stage biopharmaceutical company that aims to develop targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Th...

Myokardia Inc Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

CLDN

Caledonia Investments plc

Celladon Corporation is a clinical-stage biotechnology company that specializes in developing cardiovascular gene therapy and calcium dysregulation. Its lead product candidate, MYDICAR, utilizes ge...

Caledonia Investments plc Annual Report 2023

Healthcare Biotechnology LSE 51-200

AVEO

AVEO Pharmaceuticals

AVEO Pharmaceuticals is a company that focuses on cancer therapeutics. Their goal is to discover, develop and sell targeted therapies that can make a difference for cancer patients. The company is ...

AVEO Pharmaceuticals Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

ZSAN

Zosano Pharma Corporation

Zosano Pharma Corporation is a biopharmaceutical company that specializes in developing innovative products for patients who have limited access to existing therapies. Their transdermal microneedle...

Zosano Pharma Corporation Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

NXTC

NextCure

NextCure Inc., a leading clinical-stage biopharmaceutical firm, is making strides in the field of immunomedicine by developing advanced therapies to combat cancer and other immune-related diseases....

NextCure Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200